| scholarly article | Q13442814 |
| P356 | DOI | 10.3892/OR.2011.1433 |
| P698 | PubMed publication ID | 21874260 |
| P50 | author | Ryuichi Noguchi | Q57100205 |
| P2093 | author name string | Hiroshi Fukui | |
| Hitoshi Yoshiji | |||
| Kosuke Kaji | |||
| Yasuhide Ikenaka | |||
| Yosuke Aihara | |||
| Masayoshi Sawai | |||
| Masahisa Toyohara | |||
| Masahito Uemura | |||
| Akira Mitoro | |||
| Junichi Yamao | |||
| Masaharu Yamazaki | |||
| Masao Fujimoto | |||
| Motoyuki Yoshida | |||
| Chie Morioka | |||
| P433 | issue | 6 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| randomized controlled trial | Q1436668 | ||
| P304 | page(s) | 1547-1553 | |
| P577 | publication date | 2011-08-24 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial | |
| P478 | volume | 26 |
| Q36701534 | Angiotensin and systems thinking: wrapping your mind around the big picture |
| Q37334109 | Branched-chain amino acids in liver diseases |
| Q37276989 | Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance |
| Q52598231 | Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study. |
| Q30235047 | Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies |
| Q35686376 | Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis |
| Q99583816 | Exploring new pathways in the treatment of hepatocellular cancer |
| Q28078113 | Local ablative treatments for hepatocellular carcinoma: An updated review |
| Q24197811 | Nutritional support for liver disease |
| Q41921861 | Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine |
| Q92573164 | Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma |
| Q47863448 | Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Q89677940 | The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis |
| Q92802002 | Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System |
| Q47106953 | Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma |
Search more.